| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HARS2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |
| mRNA | DLG3 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | RMND5A | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | C14orf159 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | NFATC1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | TMED5 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | BCL3 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | MIS12 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | PPM1D | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | ZNF813 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
